UBS/PUT/PFIZER INC/37/0.1/20.12.24 Share Price

Warrant

CH1265393202

Market Closed - Deutsche Boerse AG 09:56:54 03/07/2024 pm IST
0.87 EUR +1.16% Intraday chart for UBS/PUT/PFIZER INC/37/0.1/20.12.24
Current month+2.35%
1 month+19.18%
Date Price Change
03/24/03 0.87 +1.16%
02/24/02 0.86 +4.88%
01/24/01 0.82 -3.53%
28/24/28 0.85 -2.30%
27/24/27 0.87 -2.25%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 09:56 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer UBS
WKN UL4W48
ISINCH1265393202
Date issued 27/04/2023
Strike 37 $
Maturity 20/12/2024 (170 Days)
Parity 10 : 1
Emission price 0.33
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.13
Lowest since issue 0.248
Delta-0.86x
Omega 2.504
Premium1.2x
Gearing2.91x
Moneyness 1.332
Difference Strike 9.3 $
Difference Strike %+25.14%
Spread 0.05
Spread %5.49%
Intrinsic value 0.8621

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus